Poseida Therapeutics Investor Relations Material
Latest events
Study Result
Poseida Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Poseida Therapeutics Inc
Access all reports
Poseida Therapeutics, Inc. (PSTX) is a clinical-stage biopharmaceutical company that specializes in developing innovative cell and gene therapies. These therapies aim to provide cures for cancers and genetic diseases by leveraging non-viral gene engineering technologies. Poseida's product pipeline includes both autologous and allogeneic chimeric antigen receptor T cell (CAR-T) therapies, which are at the forefront of treating hematological malignancies and solid tumors. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Poseida Therapeutics Inc
Study Result
Poseida Therapeutics Inc
R&D Day 2024
Poseida Therapeutics Inc
Latest articles
Texas Instruments: From Calculators to Master Capital Allocators
Texas Instruments has undergone many transformations from its origins in oil exploration to become one of the world's largest semiconductor producers.
11 Oct 2024
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Ticker symbol
PSTX
Country
🇺🇸 United States